MedPath

VARICELLA ZOSTER IMMUNE GLOBULIN INJ

VARICELLA ZOSTER IMMUNE GLOBULIN INJ

Discontinued
DIN Number

00554286

Drug Class

Human

Market Date

Jan 26, 1982

Company
HC

massachusetts public health biologic laboratories

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00554286
AIG Number0115174001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BB03 VARICELLA/ZOSTER IMMUNOGLOBULIN
Product Specifications
Dosage FormLiquid
Route of AdministrationIntramuscular
AHFS Classification80:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN)Active
Strength: 125 UNIT / 2.5 ML
Monograph: VARICELLA ZOSTER IMMUNOGLOBULIN (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.